Replacement of specific coagulation factors in patients with burn: A review

Burns

Volumn 39, Issue 4, 2013, Pages 543-548

  Lavrentieva, Athina ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

Antithrombin; Burn; Coagulation; Inflammation; Outcome; Protein C; Recombinant factor VIIa

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR; PROTEIN C; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; THROMBOMODULIN;

BLEEDING; BLOOD CLOTTING; BLOOD TRANSFUSION; BURN; BURN PATIENT; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG FATALITY; DRUG WITHDRAWAL; FLUID RESUSCITATION; HOSPITALIZATION; HUMAN; INFLAMMATION; LENGTH OF STAY; LEUKOCYTE ACTIVATION; NECROTIZING FASCIITIS; PNEUMONIA; REFRACTORY THROMBOCYTOPENIA; REVIEW; SEPSIS; SEPTIC SHOCK; SKIN TRANSPLANTATION; THROMBOSIS; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME;

ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BURNS; HUMANS; INFLAMMATION;

EID: 84877099995     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2012.12.009     Document Type: Review

References (36)

1. S. Wells, M. Sissons, and P.S. Hasleton Quantitation of pulmonary megakaryocytes and fibrin thrombi in patients dying from burns Histopathology 8 1984 517 527
2. A. Lavrentieva, T. Kontakiotis, M. Bitzani, G. Papaioannou-Gaki, A. Parlapani, and O. Thomareis Early coagulation disorders after severe burn injury: impact on mortality Intensive Care Med 34 4 2008 700 706
3. R.H. Bartlett, S.V. Fong, G. Maruggo, T. Hardeman, and V. Anderson Coagulation and platelets changes after thermal injury in man Burns 7 1981 370 377
4. A. Kowal-Vern, R.L. Gamelli, J.M. Walenga, D. Hoppensteadt, M. Sharp-Pucci, and H.R. Schumacher The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to the clinical state J Trauma 33 1992 50 56
5. G. Lippi, L. Ippolito, and G. Cervellin Disseminated intravascular coagulation in burn injury Semin Thromb Hemost 36 4 2010 429 436
6. S. Rehberg, P. Enkhbaatar, R.A. Cox, and D.L. Traber Coagulopathy after burn and smoke inhalation injury: the evidence is there, let's take advantage of it! J Trauma Acute Care Surg 72 4 2012 1121 1122
7. E.A. Mann, M.M. Baun, J.C. Meininger, and C.E. Wade Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature Shock 37 1 2012 4 16
8. A. Garcia-Avello, J.A. Lorente, J. Cesar-Perez, L.J. Garcia-Frade, R. Alvarado, and J.M. Arevalo Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma Thromb Res 89 1998 59 64
9. M. Niedermayr, W. Schramm, L. Kamolz, D. Andel, W. Römer, and K. Hoerauf Antithrombin deficiency and its relationship to severe burns Burns 33 2 2007 173 178
10. A. Kowal-Vern, V. McGill, J.M. Walenga, and R.L. Gamelli Antithrombin(H) concentrate infusions are safe and effective in patients with thermal injuries J Burn Care Rehabil 21 2 2000 115 127
11. A. Kowal-Vern, J.M. Walenga, V. McGill, and R.L. Gamelli The impact of antithrombin (H) concentrate infusions on pulmonary function in the acute phase of thermal injury Burns 27 1 2001 52 60
12. A. Kowal-Vern, and B.A. Latenser Antithrombin (human) concentrate infusion in pediatric patients with >50% TBSA burns Burns 29 6 2003 615 618
13. A. Lavrentieva, T. Kontakiotis, M. Bitzani, A. Parlapani, O. Thomareis, and H. Scourtis The efficacy of antithrombin administration in the acute phase of burn injury Thromb Haemost 100 2 2008 286 290
14. R. Rossaint, B. Bouillon, V. Cerny, T.J. Coats, J. Duranteau, and E. Fernández-Mondéjar Task force for advanced bleeding care in trauma management of bleeding following major trauma: an updated European guideline Crit Care 14 2 2010 R52
15. M. Nisanci, M. Eski, I. Sahin, S. Ilgan, and S. Isik Saving the zone of stasis in burns with activated protein C: an experimental study in rats Burns 36 2010 397 402
16. F.J. Walker, P.W. Sexton, and C.T. Esmon The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V Biochim Biophys Acta 571 1979 333 339
17. A. Mizutani, K. Okajima, M. Uchiba, and T. Noguchi Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation Blood 95 12 2000 3781 3787
18. F.B. Taylor Jr., A. Chang, C.T. Esmon, A. D'Angelo, S. Vigano-D'Angelo, and K.E. Blick Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon J Clin Invest 79 3 1987 918 925
19. K. Murakami, K. Okajima, M. Uchiba, M. Johno, T. Nakagaki, and H. Okabe Activated protein C attenuates endotoxininduced pulmonary vascular injury by inhibiting activated leukocytes in rats Blood 87 2 1996 642 647
20. K. Murakami, K. Okajima, M. Uchiba, M. Johno, T. Nakagaki, and H. Okabe Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production Am J Physiol 272 1997 L197 L202
21. C. Green, J. Dinnes, A. Takeda, J. Shepherd, D. Hartwell, and C. Cave Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris1) for the treatment of severe sepsis in adults: a systematic review and economic evaluation Health Technol Assess 9 11 2005
22. J.A. Russell Management of sepsis N Engl J Med 355 16 2006 1699 1713
23. R.P. Dellinger, J.M. Carlet, H. Masur, H. Gerlach, T. Calandra, and J. Cohen Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Crit Care Med 32 3 2004 858 874
24. G.R. Bernard, J.L. Vincent, P.F. Laterre, S.P. LaRosa, J.F. Dhainaut, and A. Lopez-Rodriguez Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 10 2001 699 709
25. A.C. Kalil, and S.P. LaRosa Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression Lancet Infect Dis 12 9 2012 678 686
26. V.M. Ranieri, B.T. Thompson, P.S. Barie, J.F. Dhainaut, I.S. Douglas, and S. Finfer Drotrecogin alfa (activated) in adults with septic shock N Engl J Med 366 2012 2055 2206
27. J. Weintraub, T. Satterwhite, and M. Allo The use of drotrecogin alfa recombinant activated protein C for severe sepsis in the critically burned patient: a new treatment approach Burns 32 6 2006 783 787
28. M.E. Brunsvold, S. Arbabi, M. Dimo, and W. Wahl Drotrecogin alfa in patients with burns and soft tissue injury Drotrecogin alfa in patients with burns and soft tissue injury J Burn Care Res 29 4 2008 676 678
29. M. Hoffman A cell-based model of coagulation and the role of factor VIIa Blood Rev 17 Suppl. 1 2003 S1 S5
30. P.W. Friederich, C.P. Henny, E.J. Messelink, M.G. Geerdink, T. Keller, and K.H. Kurth Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial Lancet 361 2003 201 205
31. M. Pychynska-Pokorska, J.J. Moll, W. Krajewski, and P. Jarosik The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass Pediatr Crit Care Med 5 2004 246 250
32. P.C. Spinella, J.G. Perkins, D.F. McLaughlin, S.E. Niles, K.W. Grathwohl, and A.C. Beekley The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion J Trauma 64 2 2008 286 293
33. H. Lier, B.W. Böttiger, J. Hinkelbein, H. Krep, and M. Bernhard Coagulation management in multiple trauma: a systematic review Intensive Care Med 37 4 2011 572 582
34. P.I. Johansson, K. Eriksen, and B. Alsbjørn Rescue treatment with recombinant factor VIIa is effective in patients with life-threatening bleedings secondary to major wound excision: a report of four cases J Trauma 61 4 2006 1016 1018
35. P.I. Johansson, K. Eriksen, S.L. Nielsen, R. Rojkjaer, and B. Alsbjørn Recombinant FVIIa decreases perioperative blood transfusion requirement in burn patients undergoing excision and skin grafting - results of a single centre pilot study Burns 33 4 2007 435 440
36. J.T. Martin, F. Alkhoury, B.C. McIntosh, P. Fidler, and J. Schulz Recombinant factor VIIa: hemostatic adjunct in the coagulopathic burn patient Eplasty 1 9 2009 e27